Abstract
Objectives:
The article describes the theoretical background of the diagnosis and therapy of the ESES syndrome.
Methods:
The assessment and treatment of children with ESES in a child-psychiatric setting is shown. The underlying data have been taken from 18 outpatients with or without epileptic seizures.
Results:
The early diagnosis of non-specific symptoms and the anti-epileptic treatment probably play an important role in preventing the progression of ultrastructural brain damage. Sultiam is the drug of first preference.
Publication types
-
Case Reports
-
Clinical Trial
MeSH terms
-
Anti-Anxiety Agents / therapeutic use
-
Anticonvulsants / administration & dosage
-
Anticonvulsants / therapeutic use*
-
Benzodiazepines*
-
Child
-
Child, Preschool
-
Clobazam
-
Developmental Disabilities / etiology*
-
Developmental Disabilities / physiopathology
-
Drug Therapy, Combination
-
Electroencephalography*
-
Epilepsy, Rolandic / complications
-
Epilepsy, Rolandic / diagnosis
-
Epilepsy, Rolandic / drug therapy*
-
Epilepsy, Rolandic / physiopathology
-
Female
-
Humans
-
Male
-
Syndrome
-
Thiazines / therapeutic use
-
Treatment Outcome
-
Valproic Acid / therapeutic use
Substances
-
Anti-Anxiety Agents
-
Anticonvulsants
-
Thiazines
-
Benzodiazepines
-
Clobazam
-
Valproic Acid
-
sulthiame